Back to resultsComparison of Buprenorphine and Methadone - 3
Primary Purpose
Opioid-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Buprenorphine
Sponsored by
About this trial
This is an interventional treatment trial for Opioid-Related Disorders
Eligibility Criteria
Please contact site for information.
Sites / Locations
- Washington DC VA
Outcomes
Primary Outcome Measures
Withdrawal severity
Opiate agonist symptoms
Secondary Outcome Measures
Full Information
NCT ID
NCT00000334
First Posted
September 20, 1999
Last Updated
January 30, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Washington D.C. Veterans Affairs Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00000334
Brief Title
Comparison of Buprenorphine and Methadone - 3
Official Title
Pharmacological Comparison of Buprenorphine and Methadone
Study Type
Interventional
2. Study Status
Record Verification Date
December 2002
Overall Recruitment Status
Completed
Study Start Date
December 1, 2002 (Actual)
Primary Completion Date
November 1, 2004 (Actual)
Study Completion Date
January 15, 2005 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Washington D.C. Veterans Affairs Medical Center
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to compare agonist and antagonist profile associated with buprenorphine vs. methadone during opiate withdrawal.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Opioid-Related Disorders
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Buprenorphine
Primary Outcome Measure Information:
Title
Withdrawal severity
Title
Opiate agonist symptoms
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
23 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven Deutsch, M.D.
Organizational Affiliation
Washington D.C. Veterans Affairs Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Washington DC VA
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20422
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Comparison of Buprenorphine and Methadone - 3
We'll reach out to this number within 24 hrs